JIMHANG CAPITAL
A New Medical School Should Anchor Research-Driven Care
This page contains a column summary and source reference. The date above belongs to the original publication. Read the original source for the full argument.
Column summary
The HKSAR chose HKUST for HK's third medical school. This is more than one more MBBS pipeline — it's a bet that AI, engineering and clinical research can reshape HK's biomedical future.
中文摘要
着重医疗科技研发，展现新医学院价值
港科大获批筹办本港第三所医学院。这不仅是多培养医生，更是让 AI、工程与临床研究融合，重塑香港生物医药与医疗科技的未来。
Original source
Author: Justin Zhan (詹培勋 / 詹培勛).
Read the full article at its publisher ↗https://www.wenweipo.com/a/202511/20/AP691e2678e4b02250062c9af5.html
About the author
Justin Zhan, founder of Jimhang Capital, is a Hong Kong University of Science and Technology graduate with long-standing experience across technology entrepreneurship, venture incubation, Hong Kong–Shenzhen collaboration and industrial resources.
Founder profile and public references →More columns
- Reshaping Sci-Tech Competitiveness with Patient Capital
- Dare to Innovate Institutions — Bring Out Hetao's True Function
- Zhijiang Surrender Warns the Future — Remember History, Stand Resilient
Page compiled: